Recently, Jiudian Hongyang’s International Expansion Department made a remarkable appearance at the Expofarma, held at the World Trade Center in Mexico City.

The Expofarma is one of the longest-running and most prestigious trade shows in the pharmaceutical field in Latin America. This year's event covered more than 16,000 square meters of exhibition space, with over 330 exhibitors, attracting more than 8,000 professional visitors from over 10 countries and regions. The expo not only provided a platform for exhibitors to showcase their products and services but also facilitated direct communication between exhibitors and professionals from the pharmaceutical, chemical, and medical device industries.

As a leading player in China's pharmaceutical sector, JiuDian Hongyang attended this event with a variety of core products and innovative achievements. The company’s participation aimed to deepen its expansion into the Latin American market, strengthen communication and collaboration with international peers, and enhance its global brand presence. Overcoming time zone differences and language barriers, the International Expansion Department showcased JiuDian Hongyang’s leading APIs and excipients to Latin American customers, such as chlorprothixene maleate, mebeverine maleate, and levocetirizine hydrochloride.

During the event, JiuDian Hongyang’s booth attracted numerous pharmaceutical companies, distributors, and professionals from Mexico and surrounding countries. These visitors expressed strong interest in the company’s products and engaged in in-depth discussions about product information, collaboration models, and more. They gained a comprehensive understanding of JiuDian Hongyang’s R&D capabilities, production processes, quality management systems, and overall strength, significantly boosting confidence in potential cooperation.

Additionally, the company’s representatives were warmly invited by local client Retecma to visit their office in Mexico City. Through discussions with Retecma’s General Manager and Purchasing Manager, the companies deepened their mutual understanding, and many ongoing raw material and excipient projects made substantial progress.

“In a time of increasing international competition and geopolitical volatility in 2025, going global is not a choice, but a necessity,” said JiuDian Hongyang. In 2025, the company is actively expanding its international market presence by participating in well-known international exhibitions, strengthening connections with global customers, and exploring more cooperation opportunities. Attending the Expofarma  is a key step in Jiudian Hongyang’s internationalization strategy. Moving forward, the company will continue to increase R&D investment, enhance product quality, and improve its competitiveness, with the goal of attracting customers from all over the world and establishing a prominent international market presence.